D. Berry

Statistics and Probability · Journal of Clinical Oncology · 1986–2020

A researcher in the Science corpus: 20 papers; trusts 1 researcher and is trusted by 25 researchers here, as inferred from the citation graph.

Subfields

Statistics and Probability — 5 citations into it; #2,582 of 12,932 by trust here, #3,330 by citations

Whom D. Berry trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts D. Berry overall

Papers from D. Berry's perspective

Ordered by how strongly the researchers D. Berry trusts endorse each paper. Same corpus, a different order for every researcher.

On a Measure of the Information Provided by an Experiment
On the Problem of the Most Efficient Tests of Statistical Hypotheses
WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility (Statistics and computing)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. (Journal of the National Cancer Institute)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. (Journal of Clinical Oncology)
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. (New England Journal of Medicine)
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. (Journal of Clinical Oncology)
Triple-negative breast cancer. (Clinical Journal of Oncology Nursing)
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. (Journal of the American Medical Association (JAMA))

Their papers

Statistical models in epidemiology, the environment, and clinical trials (2000) — 188 citations
Bayesian clinical trials (2006) — 707 citations
Relationship Between Bayesian and Frequentist Sample Size Determination (2005) — 57 citations
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA (2020) — 1,145 citations
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody (2020) — 688 citations
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. (2015) — 1,364 citations
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance). (2015) — 867 citations
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. (2013) — 1,167 citations
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review (2012) — 1,194 citations
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. (2010) — 1,220 citations
Bayesian Clinical Trials at the University of Texas M. D. Anderson Cancer Center (2009) — 101 citations
The decrease in breast-cancer incidence in 2003 in the United States. (2007) — 988 citations
Effect of screening and adjuvant therapy on mortality from breast cancer. (2006) — 1,479 citations
Symmetrized Percent Change for Treatment Comparisons (2006) — 69 citations
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. (2005) — 7,387 citations
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. (2005) — 1,168 citations
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. (2004) — 1,025 citations
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. (2003) — 1,318 citations
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. (2003) — 1,546 citations
Bandit Problems: Sequential Allocation of Experiments. (1986)